Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5090749
Max Phase: Preclinical
Molecular Formula: C48H60N12O7S2
Molecular Weight: 981.22
Molecule Type: Unknown
Associated Items:
ID: ALA5090749
Max Phase: Preclinical
Molecular Formula: C48H60N12O7S2
Molecular Weight: 981.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCn2cc(CCCS(=O)(=O)c3ccc(Nc4nccc(-c5cnc(C)n5C(C)C)n4)cc3)nn2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C48H60N12O7S2/c1-30(2)60-32(4)50-25-41(60)39-18-19-49-47(54-39)53-35-14-16-38(17-15-35)69(65,66)22-8-9-36-26-58(57-56-36)20-21-67-28-42(62)55-44(48(5,6)7)46(64)59-27-37(61)23-40(59)45(63)51-24-33-10-12-34(13-11-33)43-31(3)52-29-68-43/h10-19,25-26,29-30,37,40,44,61H,8-9,20-24,27-28H2,1-7H3,(H,51,63)(H,55,62)(H,49,53,54)/t37-,40+,44-/m1/s1
Standard InChI Key: XVCGNRHPFMMQTF-OUZJXKGJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 981.22 | Molecular Weight (Monoisotopic): 980.4149 | AlogP: 5.23 | #Rotatable Bonds: 20 |
Polar Surface Area: 241.34 | Molecular Species: NEUTRAL | HBA: 17 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.49 | CX Basic pKa: 6.00 | CX LogP: 2.82 | CX LogD: 2.80 |
Aromatic Rings: 6 | Heavy Atoms: 69 | QED Weighted: 0.07 | Np Likeness Score: -1.34 |
1. Hati S, Zallocchi M, Hazlitt R, Li Y, Vijayakumar S, Min J, Rankovic Z, Lovas S, Zuo J.. (2021) AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss., 226 [PMID:34560429] [10.1016/j.ejmech.2021.113849] |
Source(1):